Hemodiafiltration with online regeneration of the ultrafiltrate.
暂无分享,去创建一个
C Ronco | A Brendolan | P M Ghezzi | R Gervasio | C. Ronco | C. Tetta | M. Arias | A. Brendolan | P. Ghezzi | F. Fiorini | C Tetta | G La Greca | F Fiorini | M Arias | A L Marinez de Francisco | G. La Greca | R. Gervasio | A. L. Marinez de Francisco
[1] R. Vanholder,et al. Uremic Ultrafiltrate Inhibits Platelet-Activating Factor Synthesis , 1999, Blood Purification.
[2] C. Ronco,et al. Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. , 1995, Critical care medicine.
[3] D. Inthorn,et al. Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. , 1995, Contributions to nephrology.
[4] J. Cavaillon,et al. C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. , 1987, Journal of immunology.
[5] C. Ronco,et al. Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[6] J. Winchester,et al. Extracorporeal Blood Purification Techniques: Plasmapheresis and Hemoperfusion , 1996 .
[7] R. Scandurra,et al. Perfusion of uremic blood ultrafiltrate on uncoated charcoal. , 1989, Artificial organs.
[8] I. Lundkvist,et al. Uremic serum enhances scavenger receptor expression and activity in the human monocytic cell line U937. , 1997, Kidney international.
[9] L. Minetti,et al. Hemofiltration without substitution fluid: a physiological approach to renal replacement therapy , 1987 .
[10] R. Vanholder,et al. Uraemic toxic retention solutes depress polymorphonuclear response to phagocytosis. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[11] W. van Biesen,et al. The removal of uremic toxins. , 2000, Kidney international. Supplement.
[12] P. Ghezzi,et al. Adsorption in hemodialysis. , 2000, Kidney international. Supplement.
[13] K. Berg,et al. Removal of uremic toxins and regeneration of hemofiltrate by a selective dual hemofiltration artificial kidney (SEDUFARK) system. , 1980, Clinical nephrology.
[14] P. Ghezzi,et al. Use of the Ultrafiltrate Obtained in Two-Chamber (Pfd) Hemodiafiltration as Replacement Fluid. Experimental ex vivo and in Vitro Study , 1991, The International journal of artificial organs.
[15] J. Lundahl,et al. Dialysis-induced serum factors inhibit adherence of monocytes and granulocytes to adult human endothelial cells. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] R. Vanholder,et al. HPLC fractions of human uremic plasma inhibit the RBC membrane calcium pump. , 1997, Kidney international.
[17] S. Cerutti,et al. Effect of a new model of hemodialysis potassium removal on the control of ventricular arrhythmias. , 1996, Kidney international.
[18] M. Schrader,et al. Composition of the peptide fraction in human blood plasma: database of circulating human peptides. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[19] P. Ghezzi,et al. Technical requirements for rapid high-efficiency therapy in uremic patients. Paired filtration-dialysis (PFD) with a two-chamber technique. , 1987, ASAIO transactions.
[20] M. Bennish,et al. Interleukin‐1β (IL‐1β), IL‐1 receptor antagonist, and TNFα production in whole blood , 1992 .